Rigorous focus on paclitaxel-related mortality in femoropopliteal artery disease
- PMID: 31864645
- DOI: 10.1016/j.jvs.2019.10.010
Rigorous focus on paclitaxel-related mortality in femoropopliteal artery disease
Abstract
Paclitaxel-coated balloons and stents have emerged as the most promising strategy for the inhibition of neointimal hyperplasia after endovascular treatment of the femoropopliteal artery. However, a few months ago, cause for concern was raised in a systematic review and meta-analysis of randomized controlled trials investigating paclitaxel-coated balloon angioplasty or paclitaxel-coated metal stents in the femoral and popliteal arteries. This editorial reviews the data available to date relative to the potential increased risk of mortality after the use of drug-eluting technologies in the femoropopliteal segment.
Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Comment on
-
Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.J Vasc Surg. 2019 Sep;70(3):981-995.e10. doi: 10.1016/j.jvs.2019.01.080. Epub 2019 May 21. J Vasc Surg. 2019. PMID: 31126769
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical